Merrimack Pharmaceuticals - M&A Summary and Business Overview

Life ScienceCompany

Merrimack Pharmaceuticals M&A Summary

Merrimack Pharmaceuticals has acquired 1 company. It has also divested 1 asset.

It’s largest disclosed sale occurred in 2017, when it sold Merrimack Pharmaceuticals - Oncology Assets to Ipsen SA for $575M. Merrimack Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Merrimack Pharmaceuticals Business Overview

Where is Merrimack Pharmaceuticals headquartered?

Merrimack Pharmaceuticals is headquartered in Cambridge, Massachusetts.

What sector is Merrimack Pharmaceuticals in?

Merrimack Pharmaceuticals is a life science company.

When was Merrimack Pharmaceuticals founded?

Merrimack Pharmaceuticals was founded in 1993.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Merrimack Pharmaceuticals, Inc.

One Kendall Square Suite B7201,
Cambridge, Massachusetts 02139
United States,
(617) 441-1000
www.merrimackpharma.com

Merrimack Pharmaceuticals, Inc. is a bio-pharmaceutical company develops commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # 1 - - - - - 1
vol $575M $575M
  2

Most Recent M&A

Company Date Value Type
Merrimack Pharmaceuticals, Inc. - Oncology Assets 2017-01-08 575M USD Divestiture
Cambridge, Massachusetts
HERMES Biosciences, Inc. 2009-12-07 - Add-on Acquisition
South San Francisco, California
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - 1 (100%) 575M (100%)
Total 1 - 1 $575M

By Geo

State/Country Buy Value Sell Value
United States 1 - 1 575M
  California 1 - - -
  Massachusetts - - 1 575M
Total 1 - 1 $575M

Deal Values

sell # Total
$100M to $1B 1 $575M
TOTAL $575M
Largest Merrimack Pharmaceuticals, Inc. - Oncology Assets
$575M (2017-01-08)

M&A Connections

Deals
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.